Analysts expect over 2019 rising revenue GlaxoSmithKline, quite high dividend

Tomorrow the English GlaxoSmithKline will report its past quarters results. Over the current book year the total revenue will be 31,79 billion GBp (consensus estimates). This is slightly more than 2017's revenue of 30,82 billion GBp.

Historical revenues and results GlaxoSmithKline plus estimates 2018

fundamental data

The analysts expect for 2018 a net profit of 5,56 billion GBp. Most of the analysts anticipate on a profit per share of 112 GBp. Based on this the price/earnings-ratio is 14,01.

Huge dividend GlaxoSmithKline

Per share the analysts expect a dividend of 80 GBp per share. Thus the dividend yield equals 5,1 percent. The average dividend yield of the pharmaceutical companies is a limited 0,5 percent.

Latest estimates around 1712 GBp

The most recent recommendations for the pharmaceutical company are from UBS, Independent Research and HSBC.

GlaxoSmithKline's market value equals around 7780,01 billion . The GlaxoSmithKline stock was the past 12 months quite volatile. Since last April the stock is 13 percent higher. This year the stock price moved between 1409 and 1649 GBp. Since 2008 the stock price is almost 52 percent higher.

At 10.09 the stock trades 0,57 percent higher at 1569,2 GBp.

Price data GlaxoSmithKline 2007-2018

fundamental data glaxosmithkline News Wire & Equity Research: +31 084-0032-842

Copyright B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.